Nuffield Trust says supply chains have shifted, with medicines for epilepsy and cystic fibrosis among those now scarce. Read More
The UK generic drug industry is not ready to comply with new post-Brexit labelling rules for medicines entering Northern Ireland, … Read…
The ‘Unintended Consequences’ Of UK’s New Pricing Scheme. 09 Oct 2024. News. Ian Schofield @ … Read More
Reliance procedures have been used for most recent new drug approvals, and will continue to be employed in future, although…
Patricia Cope, 81, needs to take a steady supply of Creon enzyme capsules in order to digest her food as…
The UK pharmaceutical industry is asking for more clarification post-brexit MHRA guidelines. Whilst Prime Minister Rishi Sunak and Labour party … Read…
“More people blame Brexit than anything else for supply problems, survey finds.” https://www.theguardian.com/society/article/2024/jun/16/almost-half-uk-adults-struggling-prescription-drugs-medicine-shortages?CMP=share_btn_url
The UK’s drug regulator, the MHRA, has taken a hit in terms of capacity and funding post-Brexit, and could benefit…
Report from Nuffield Trust health think-tank highlights impact of leaving EU on medicine supply chains. Read More
“Since leaving the EU in 2020, shortages have become the ‘new normal’.” https://news.sky.com/story/brexit-has-made-uk-medicine-shortages-worse-research-suggests-13117617